XML 55 R24.htm IDEA: XBRL DOCUMENT v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Jan. 31, 2019
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2019
Significant Accounting Policies [Line Items]        
Severance payment expenses   $ 132 $ 137  
Severance expenses   $ 132    
Number of antidilutive securities excluded from computation of earnings per share   6,255,235 6,517,102  
Revenues recorded in revenue recognition   $ 89 $ 502  
From Amgen [Member]        
Significant Accounting Policies [Line Items]        
Non-refundable and non-creditable initial technology access fee payment, including payment for the first year of preclinical services $ 725      
Additional amount paid for services to be recognized upon commencement of the pre-clinical Research and Development services       $ 225
Right to use intellectual property       $ 500